{"id":"W2065016129","doi":"10.1002/cncr.26204","title":"Dasatinib combined with docetaxel for castration‐resistant prostate cancer","year":2011,"lang":"en","type":"article","venue":"Cancer","topic":"Bone health and treatments","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute; Bristol-Myers Squibb; U.S. Department of Defense","keywords":"Docetaxel; Dasatinib; Medicine; Prostate cancer; Internal medicine; Oncology; Urology; Bone remodeling; Discontinuation; Cancer; Gastroenterology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003090606,0.0004460598,0.001334706,0.0003936938,0.0002881289,0.0004539534,0.0004192679,0.0002640928,0.002008538],"category_scores_gemma":[0.0004292776,0.000158149,0.0004770774,0.0004213628,0.0003150804,0.0001980065,0.0002787266,0.0007586856,0.0005155639],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007735003,"about_ca_system_score_gemma":0.0006303221,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009473036,"about_ca_topic_score_gemma":0.004018928,"domain_scores_codex":[0.9997322,0.00006504114,0.00003128835,0.00004733225,0.00006739746,0.00005660311],"domain_scores_gemma":[0.999851,0.00002271775,0.00004159544,0.00001115381,0.0000149491,0.00005860289],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.04904816,0.00657282,0.02151767,0.003987791,0.002195629,0.003393344,0.0003856657,0.008828704,0.1535351,0.0009201686,0.01126099,0.738354],"study_design_scores_gemma":[0.1805044,0.2946501,0.1379532,0.0006477241,0.003928376,0.0362801,0.0004579447,0.01469023,0.1703655,0.001807877,0.1584505,0.0002642008],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9481364,0.04328513,0.001153092,0.0009454478,0.0003589607,0.0006293381,0.0002980933,0.000145693,0.00504781],"genre_scores_gemma":[0.9907176,0.006956078,0.0007313513,0.0001771832,0.0001198958,0.00009984135,0.0002364758,0.000009998774,0.0009515391],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002008538,"threshold_uncertainty_score":0.006719172,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06264083027792848,"score_gpt":0.3360566356297487,"score_spread":0.2734158053518203,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}